These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21088421)

  • 21. The role of adjuvant therapy for pancreatic cancer.
    Magee CJ; Ghaneh P; Hartley M; Sutton R; Neoptolemos JP
    Expert Opin Investig Drugs; 2002 Jan; 11(1):87-107. PubMed ID: 11772324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Okamura Y; Kinugasa Y; Bando E; Terashima M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1403-5. PubMed ID: 21918335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question.
    Khanna A; Walker GR; Livingstone AS; Arheart KL; Rocha-Lima C; Koniaris LG
    J Gastrointest Surg; 2006 May; 10(5):689-97. PubMed ID: 16713541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
    Winer LK; Cortez AR; Ahmad SA; Wima K; Olowokure O; Latif T; Kharofa J; Patel SH
    J Surg Res; 2021 Mar; 259():442-450. PubMed ID: 33059910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
    Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW
    BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current state of adjuvant therapy in resected pancreatic adenocarcinoma.
    Bergenfeldt M; Albertsson M
    Acta Oncol; 2006; 45(2):124-35. PubMed ID: 16546857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Saif MW
    JOP; 2009 Jul; 10(4):373-7. PubMed ID: 19581737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.
    Wo JY; Childs SK; Szymonifka J; Mamon HJ; Ryan DP; Blaszkowsky LS; Kwak EL; Ferrone CR; Allen JN; Zhu AX; Wolpin BM; Chan JA; Abrams TA; McCleary NJ; Fernandez-Del Castillo C; Hong TS
    Pract Radiat Oncol; 2014; 4(2):e117-e123. PubMed ID: 24890357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy for pancreatic cancer.
    Ghaneh P; Slavin J; Sutton R; Neoptolemos JP
    Swiss Surg; 2000; 6(5):289-95. PubMed ID: 11077498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postoperative adjuvant treatment for pancreatic cancer].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Kinugasa Y; Bando E; Terashima M
    Nihon Geka Gakkai Zasshi; 2011 May; 112(3):187-90. PubMed ID: 21688463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies in the adjuvant treatment of pancreatic adenocarcinoma.
    Saif MW
    JOP; 2007 Sep; 8(5):545-52. PubMed ID: 17873458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibilities of palliation in pancreatic cancer].
    Di Costanzo F; Sdrobolini A; Gasperoni S
    Tumori; 1999; 85(1 Suppl 1):S47-53. PubMed ID: 10235081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New techniques and agents in the adjuvant therapy of pancreatic cancer.
    Raraty MG; Magee CJ; Ghaneh P; Neoptolemos JP
    Acta Oncol; 2002; 41(7-8):582-95. PubMed ID: 14651201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
    Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
    N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy of pancreatic cancer.
    Hilbig A; Oettle H
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant therapy in pancreatic cancer.
    Ghaneh P; Slavin J; Sutton R; Hartley M; Neoptolemos JP
    World J Gastroenterol; 2001 Aug; 7(4):482-9. PubMed ID: 11819814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
    Furuse J
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.